Latest Trading Suspensions News

Donaco International Limited’s shares have been suspended from trading on the ASX following court approval of its acquisition by On Nut Road Limited. This marks a significant step in the company’s transition under new ownership.

Donaco International’s acquisition scheme by On Nut Road Limited has been legally approved, triggering an imminent trading suspension and a cash payout to shareholders.

Domain Holdings Australia’s acquisition by CoStar Group has been approved by the Supreme Court of NSW, triggering a trading suspension on ASX and setting key payment dates for shareholders.

Finexia Financial Group has resumed trading following announcements of a significant business disposal and new executive appointments, signaling a pivotal restructuring phase.

Dundee Precious Metals has secured the Bosnian Competition Council's approval, clearing a major regulatory hurdle in its planned acquisition of Adriatic Metals. The deal now moves closer to completion pending shareholder and court approvals.

Energy Transition Minerals Ltd has been reinstated to the ASX following a capital raising and the strategic acquisition of the Penouta Tin-Tantalum-Niobium Mine in Spain.

Piedmont Lithium has updated the timetable for its merger with Sayona Mining, setting key dates for shareholder votes, trading suspensions, and the final merger effective date in August 2025.

Silk Logistics Holdings has secured court approval for its acquisition by DP World Australia, with shares set to be suspended on the ASX and a cash payout scheduled for shareholders.

The Supreme Court of New South Wales has approved DP World Australia’s acquisition of Silk Logistics, paving the way for a $2.14 per share cash payout to Silk shareholders and imminent suspension of Silk shares on the ASX.

Nutritional Growth Solutions Ltd (NGS) has had its trading suspension lifted following a key announcement about a capital raising, signaling renewed market activity.

HeraMED Limited has resumed trading on the ASX following the release of its quarterly reports and a significant capital raising announcement, marking a pivotal moment for the medical device company.

Syntara Limited’s trading suspension has been lifted as the company lodged its quarterly activity and cash flow reports for June 2025, reopening its shares to market activity.